MD1898G2 - Dermatologic remedy stabilized on juglone base - Google Patents

Dermatologic remedy stabilized on juglone base

Info

Publication number
MD1898G2
MD1898G2 MDA20010204A MD20010204A MD1898G2 MD 1898 G2 MD1898 G2 MD 1898G2 MD A20010204 A MDA20010204 A MD A20010204A MD 20010204 A MD20010204 A MD 20010204A MD 1898 G2 MD1898 G2 MD 1898G2
Authority
MD
Moldova
Prior art keywords
juglone
base
dermatologic
remedy
stabilized
Prior art date
Application number
MDA20010204A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD1898F1 (en
Inventor
Василе РУСУ
Игорь КАСИАН
Ана КАСИАН
Владимир ВАЛИКА
Виктор ГИКАВЫЙ
Вадим ГАВРИЛУЦА
Original Assignee
Молдо-франко-румынское совместное предприятие "ЕУРОФАРМ" с ограниченной ответственностью
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Молдо-франко-румынское совместное предприятие "ЕУРОФАРМ" с ограниченной ответственностью filed Critical Молдо-франко-румынское совместное предприятие "ЕУРОФАРМ" с ограниченной ответственностью
Priority to MDA20010204A priority Critical patent/MD1898G2/en
Publication of MD1898F1 publication Critical patent/MD1898F1/en
Publication of MD1898G2 publication Critical patent/MD1898G2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to the pharmaceutics, in particular to remedies with bactericidal and antimycotic action on juglone base having a higher stability.Summary of the invention consists in that the proposed remedy contains juglone, pharmaceutically acceptable polybasic hydroxy acid, preferably citric acid, and benzyl alcohol in the following component ratio, mass %:
MDA20010204A 2001-06-29 2001-06-29 Dermatologic remedy stabilized on juglone base MD1898G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010204A MD1898G2 (en) 2001-06-29 2001-06-29 Dermatologic remedy stabilized on juglone base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010204A MD1898G2 (en) 2001-06-29 2001-06-29 Dermatologic remedy stabilized on juglone base

Publications (2)

Publication Number Publication Date
MD1898F1 MD1898F1 (en) 2002-04-30
MD1898G2 true MD1898G2 (en) 2002-10-31

Family

ID=19739886

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010204A MD1898G2 (en) 2001-06-29 2001-06-29 Dermatologic remedy stabilized on juglone base

Country Status (1)

Country Link
MD (1) MD1898G2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
М.В., Айзенберг Л.Н., Межевалова А.Г. Юглон и его применение в медицине и ветеринарии. Бюллетень научно-технической информации, №5, Кишинев, 1958. *

Also Published As

Publication number Publication date
MD1898F1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
RS50876B (en) Use of flibanserin in the treatment of sexual disorders
WO2004021968A3 (en) Solution for ungual application
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
HK1068278A1 (en) Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group, a polyethylene glycol and an antioxidant
EP1600167A3 (en) A pyrrolidineacetamide derivative alone in combination for treatment of CNS disorders
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
EP2298812A3 (en) Remedies for juvenile chronic arthritis and related diseases
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
JP2003513039A5 (en)
AR034900A1 (en) USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
WO2003053394A3 (en) Use of apple core extracts in cosmetic or pharmaceutical co mpositions
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
AU3408901A (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
WO2005004860A3 (en) Novel solid pharmaceutical composition comprising amisulpride
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
MD1898G2 (en) Dermatologic remedy stabilized on juglone base
WO2001060343A3 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
EP1806144A3 (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
WO2000061125A3 (en) Osanetant in the treatment of mood disorders

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees